Envoy Medical Secures Patent Advancing Cochlear Implant Signal Quality
SYDNEY, Australia, December 17, 2025 — Envoy Medical, Inc. has been granted a new Australian patent for its innovative...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SYDNEY, Australia, December 17, 2025 — Envoy Medical, Inc. has been granted a new Australian patent for its innovative...
WHITE BEAR LAKE, Minn., Dec. 10, 2025 — Envoy Medical announced the successful first set of activations in the...
White Bear Lake, Minnesota — November 20, 2025 — Envoy Medical Inc. (NASDAQ: COCH) announced the issuance of U.S....
November 18, 2025 — Austin, Texas — Envoy Medical, Inc. announced it has successfully enrolled its first 10 patients...
ST. PAUL, Minn., Oct. 8, 2025 — Envoy Medical, a pioneer in fully implanted hearing device technology, has received...
